YY/T 1526-2017 (YY/T1526-2017, YYT 1526-2017, YYT1526-2017) & related versions
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | See Detail | Status | Similar PDF |
| YY/T 1526-2017 | English | 150 |
Add to Cart
|
0-9 seconds. Auto delivery.
|
Detection kit for human immunodeficiency virus 1 type(HIV-1) p24 antigen and antibodies to human immunodeficiency virus(chemiluminescence immuno-assay)
|
YY/T 1526-2017
| Valid |
YYT 1526-2017
|
Buy with any currencies (Euro, JPY, KRW...): YY/T 1526-2017 Preview this PDF: YY/T 1526-2017
YY/T 1526-2017: PDF in English (YYT 1526-2017)
YY/T 1526-2017
YY
PHARMACEUTICAL INDUSTRY STANDARD
OF THE PEOPLE’S REPUBLIC OF CHINA
ICS 11.100
C 44
Detection Kit for Human Immunodeficiency Virus 1
Type (HIV-1) P24 Antigen and Antibodies to Human
Immunodeficiency Virus (Chemiluminescence
Immuno-Assay)
ISSUED ON. MAY 02, 2017
IMPLEMENTED ON. APRIL 01, 2018
Issued by. China Food and Drug Administration
Table of Contents
Foreword ... 3
1 Scope ... 4
2 Normative References ... 4
3 Requirements ... 4
4 Test Methods ... 6
5 Mark, Label and Use Instructions ... 8
6 Package, Transportation and Storage ... 8
Bibliography ... 9
Detection Kit for Human Immunodeficiency Virus 1
Type (HIV-1) P24 Antigen and Antibodies to Human
Immunodeficiency Virus (Chemiluminescence
Immuno-Assay)
1 Scope
This Standard specifies the requirements, test methods, mark, label and use
instructions, package, transportation and storage of detection kit for antigen and
antibodies to human immunodeficiency virus (chemiluminescence immuno-assay).
This Standard is applicable to the kit perform qualitative detection of human
immunodeficiency virus 1 (HIV-1), p24 antigen and (HIV-1 p24) and HIV (including HIV-
1 and HIV-2) antibodies in the human serum and/or plasma through the light source
(including chemiluminescence analysis, immunofluorescence analysis, time-resolved
immunofluorescence analysis) excited by special substance based on the sandwich
method; namely, detection kit for antigen and antibodies to human immunodeficiency
virus.
2 Normative References
The following documents are essential to the application of this document. For the
dated documents, only the versions with the dates indicated are applicable to this
document; for the undated documents, only the latest version (including all the
amendments) are applicable to this document.
GB/T 191-2008 Packaging – Pictorial Marking for Handling of Goods
GB/T 29791.2-2013 In Vitro Diagnostic Medical Devices - Information Supplied by
the Manufacturer (Labelling) - Part 2. In Vitro Diagnostic Reagents for Professional
Use
3 Requirements
3.1 Appearance
reference product of minimum detection limit; the requirements for minimum detection
quantity is no higher than 2.5IU/mL (≤2.5IU/mL); and its matrix serum is negative.
3.3.4 Precision
Test with a national precision reference product or a standardized precision reference
product; the results are both positive, the coefficient of variation of CV≤15% (n=10).
3.4 Stability
Verification of shelf life stability and thermal stability.
a) Shelf life stability. the period of shelf life for the products specified by the
manufacturer. Take the reagent (kit) for a certain period of time before the
expiration of valid date; detect the appearance, positive reference product
compliance rate, negative reference product compliance rate, minimum
detection limit, and precision, and the like items; the results shall meet the
requirements of 3.2 and 3.3.
b) handle the reagent (kit) under the specified heating conditions (37°C); detect the
appearance, positive reference product compliance rate, negative reference
product compliance rate, minimum detection limit, precision, and the like items;
the results shall meet the requirements of 3.2 and 3.3.
NOTE 1. Thermal stability cannot be used to derive the valid date of the product; unless it is
from a derivation formula based on a large number of stability studies.
NOTE 2. Generally, a product with a valid period of 1 year and no more than 1 month is selected;
the valid period shall be half a year; and so on. However, if it exceeds the specified time, when
the product meets the requirements, it is also acceptable.
4 Test Methods
4.1 Appearance
Take visual examination with normal or corrected visual acuity under natural light, the
results shall meet the requirements of 3.1.
4.2 HIV antibody detection
4.2.1 Negative reference product compliance rate
Test with a national negative reference product or a standardized negative reference
product; operate as per the product instructions; the results shall meet the
requirements of 3.2.1.
4.4.1 Shelf life stability. take the reagent (kit) for a certain period of time before the
expiration of valid date; operate as per the product instructions; the results shall meet
the requirements of 3.4 a).
4.4.2 Thermal stability. place the reagent (kit) for certain time under certain
temperature conditions (generally 37°C); operate as per the product instructions; the
results shall meet the requirements of 3.4 b).
5 Mark, Label and Use Instructions
It shall conform to the provisions of GB/T 29791.2-2013.
6 Package, Transportation and Storage
6.1 Package
The packaging and transporting pictorial signs shall conform to the provisions of GB/T
191-2008. The packaging container shall ensure the good sealing, completeness, and
no leakage, no damage.
6.2 Transportation
The kit shall be transported as required by the manufacturer. During the transportation,
it shall be protected from moisture; prevent heavy loads from piling up; avoid direct
sunlight, rain and snow; prevent contact with acid and alkali substances; prevent the
damage to the inner and outer package.
6.3 Storage
The kit shall be stored under the conditions specified by the manufacturer.
......
| Standard ID | YY/T 1526-2017 (YY/T1526-2017) | | Description (Translated English) | Detection kit for human immunodeficiency virus 1 type(HIV-1) p24 antigen and antibodies to human immunodeficiency virus(chemiluminescence immuno-assay) | | Sector / Industry | Medical Device & Pharmaceutical Industry Standard (Recommended) | | Classification of Chinese Standard | C44 | | Classification of International Standard | 11.100 | | Word Count Estimation | 10,125 | | Date of Issue | 2017-05-02 | | Date of Implementation | 2018-04-01 | | Drafting Organization | China Institute of Food and Drug Control, Roche Diagnostics (Shanghai) Co., Ltd., Abbott Trading (Shanghai) Co., Ltd. | | Administrative Organization | National Medical Clinical Laboratory and in vitro diagnostic system standardization Technical Committee (SAC/TC 136) | | Proposing organization | China Food and Drug Administration | | Issuing agency(ies) | State Food and Drug Administration |
|